Ibex: Studies to Be Presented at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting Brigham and Women's Hospital and Champalimaud Foundation research shows high accuracy levels of Galen Breast in identifying...

Evident: Image data from multiple hospitals improves the tool’s versatility and accuracy WALTHAM, Mass., (Aug. 29, 2022) Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint...

Ibex: Galen™ Gastric demonstrated outstanding outcomes in detecting gastric cancer in a multi-site study, supporting quality diagnosis, enhanced lab efficiency and quality control Tel Aviv, Israel, June 15, 2022 – Ibex Medical...

Automated detection and quantitation of gastric immune cells in a mouse model of ­H. pylori-driven preneoplastic progression 21 OCTOBER 2021 8:00 AM – 9:00 AM PDT | 11:00 AM – 12:00 PM EDT | 4:00 PM – 5:00 PM BST Register...

The OncoLens team will be hosting a free CME event Molecular Testing in The Community Oncology Setting: Where We Are And Where We Are Going. During this session, Maria E. Arcila, MD of the Memorial Sloan Kettering Cancer Center, will...

With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab...